Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Medical Research and Opinion|March 14, 2013
Key issues in addressing the clinical and humanistic burden of short bowel syndrome in the USSteven Hofstetter, Lee Stern, Jacob Willet
International Journal of Cardiology|June 19, 2004
A pharmacoeconomic evaluation of aggressive cholesterol lowering in SwedenAnders Olsson, Roman Casciano, Lee Stern, et al.
Journal of Women'S Health (2002)|August 7, 2008
Advances in contraception: IUDs from a managed care perspectiveJohn Doyle, Lee Stern, Michael Hagan, et al.
Managed Care Interface|April 27, 2007
Use of the levonorgestrel-IUD in the treatment of menorrhagia: improving patient outcomes while reducing the need for surgical managementAndrew M Kaunitz, Lee Stern, John Doyle, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 17, 2010
Economic impact of enoxaparin after acute ischemic stroke based on PREVAILGraham Pineo, Jay Lin, Lee Stern, et al.
Pharmacoeconomics|May 18, 2005
Economic considerations in the prescribing of third-generation antidepressantsStuart Montgomery, John J Doyle, Lee Stern, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 17, 2005
A pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes in SpainJuan Antonio Gómez-Gerique, Roman Casciano, Lee Stern, et al.
Journal of Hospital Medicine|November 8, 2011
Economic impact of enoxaparin versus unfractionated heparin for venous thromboembolism prophylaxis in patients with acute ischemic stroke: a hospital perspective of the PREVAIL trialGraham Pineo, Jay Lin, Lee Stern, et al.
Journal of Comparative Effectiveness Research|April 3, 2019
Budget impact of niraparib as maintenance treatment in recurrent ovarian cancer following platinum-based chemotherapyKurt Neeser, William M O'Neil, Lee Stern, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|August 11, 2004
A pharmacoeconomic evaluation of the myocardial ischemia reduction with aggressive cholesterol lowering (MIRACL) study in CanadaRoman Casciano, Jean-Eric Tarride, Marie Claude Breton, et al.
Pageof 3